Itron, Inc. (NASDAQ:ITRI) SVP Christopher E. Ware Sells 648 Shares

Itron, Inc. (NASDAQ:ITRI) SVP Christopher E. Ware sold 648 shares of the company’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $92.90, for a total value of $60,199.20. Following the transaction, the senior vice president now directly owns 20,326 shares in the company, valued at approximately $1,888,285.40. This trade represents a 3.09 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Itron Stock Performance

ITRI stock opened at $101.81 on Wednesday. The firm has a market cap of $4.59 billion, a PE ratio of 20.86, a P/E/G ratio of 0.81 and a beta of 1.46. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. The business has a 50 day moving average of $104.99 and a 200-day moving average of $106.84. Itron, Inc. has a 12-month low of $83.60 and a 12-month high of $124.90.

Hedge Funds Weigh In On Itron

Several institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC lifted its stake in Itron by 0.5% in the third quarter. Geode Capital Management LLC now owns 1,074,940 shares of the scientific and technical instruments company’s stock valued at $114,835,000 after purchasing an additional 5,630 shares during the last quarter. First Trust Advisors LP lifted its stake in Itron by 9.1% in the fourth quarter. First Trust Advisors LP now owns 802,584 shares of the scientific and technical instruments company’s stock valued at $87,145,000 after purchasing an additional 66,637 shares during the last quarter. Norges Bank purchased a new position in Itron in the fourth quarter valued at approximately $64,615,000. Northern Trust Corp lifted its stake in Itron by 11.4% in the fourth quarter. Northern Trust Corp now owns 572,266 shares of the scientific and technical instruments company’s stock valued at $62,137,000 after purchasing an additional 58,546 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in Itron by 21.5% in the fourth quarter. Nuveen Asset Management LLC now owns 560,478 shares of the scientific and technical instruments company’s stock valued at $60,857,000 after purchasing an additional 99,142 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on ITRI. Guggenheim boosted their price objective on Itron from $128.00 to $135.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. Robert W. Baird boosted their price objective on Itron from $123.00 to $132.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. TD Cowen boosted their price objective on Itron from $125.00 to $136.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Oppenheimer boosted their price objective on Itron from $120.00 to $124.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. Finally, Roth Mkm boosted their price objective on Itron from $125.00 to $130.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $123.92.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.